CD4 and neoplasm: Another approach to reactivate the immune system employs pro-inflammatory cytokines such as interleukin-12 (IL-12), which activates NK cells, effector CD4 T cells and cytotoxic CD8 T cells and induces IFNγ expression for direct tumor cell targeting and antiangiogenic effects (3).